Great to see this high impact publication on the use of Semaglutide (Ozempic) in #T1D from a fantastic group of researchers in Montreal.

https://www.nature.com/articles/s41591-024-03463-z

Comments

Posting Rules

  • Be respectful to others
  • No spam or self-promotion
  • Stay on topic
  • Follow Bluesky's terms of service